Tag Archives: Xeljanz
-
-
Investigation of Xeljanz Cancer and Heart Risks Launched in Canada
-
Xeljanz Cancer Warnings Leave More Questions Than Answers
-
Xeljanz Heart and Cancer Concerns May Be Impacting FDA Review of Rinvoq for Psoriatic Arthritis
-
Pfizer Files Lawsuit Over Xeljanz Generic Application
-
Xeljanz Problems Highlighted in Study Data May Lead to New FDA Restrictions: Report
-
Xeljanz Side Effects May Increase Risk of Cancer, Serious Heart Problems: FDA Alert
-
FDA Approves High-Dose, Extended-Release Version of Xeljanz, Despite Blood Clot Risks
-
Blood Clot Problems from Xeljanz Draw Updated EMA Warning for High Risk Patients
-
Xeljanz Black Box Warning Added by FDA, Due to Risk of Blood Clots and Death